Customized dosing helps address this limitation
From the red carpets of Hollywood to NHS clinics across the UK, this new class of medicines, known as GLP-1 receptor agonists, is rapidly changing the way we approach obesity
Male germ cell-specific knockout of cholesterogenic cytochrome P450 lanosterol 14-demethylase (Cyp51)
PlexusDx patients who complete the Precision Peptide Genetic Test receive personalized dosing that may optimize results within their genetic capacity
Preclinical data suggest interactions with dopamine pathways, but human trials remain limited
Comprehensive Insight Beyond weight, monitor changes in body fat percentage, lean muscle mass, posture, and more